State Street’s Edesa Biotech EDSA Stock Holding History

State Street’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$309K	Hold	37,979	–	–	﹤0.01%	3707
2026 Q1	$199K	Buy	37,979 +19,300	+103%	+$57.9K	﹤0.01%	3889
2025 Q4	$27.1K	Buy	+18,679	New	+$36.6K	﹤0.01%	4219
2023 Q4	–	Sell	-6,282	Closed	-$27.5K	–	4453
2023 Q3	$27.5K	Hold	6,282	–	–	﹤0.01%	4404
2023 Q2	$35.2K	Hold	6,282	–	–	﹤0.01%	4501
2023 Q1	$40.1K	Hold	6,282	–	–	﹤0.01%	4555
2022 Q4	$95K	Buy	6,282 +2,828	+82%	+$21.1K	﹤0.01%	4384
2022 Q3	$22K	Hold	3,454	–	–	﹤0.01%	4816
2022 Q2	$39K	Buy	3,454 +186	+6%	+$2.74K	﹤0.01%	4771
2022 Q1	$68K	Hold	3,268	–	–	﹤0.01%	4736
2021 Q4	$129K	Buy	3,268 +1,286	+65%	+$61.5K	﹤0.01%	4512
2021 Q3	$102K	Buy	+1,982	New	+$77.1K	﹤0.01%	4539

Other funds holding EDSA

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street's EDSA Position: Q2 2026 in Review

State Street held its Edesa Biotech (EDSA) position steady in Q2 2026 at 37,979 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #3707.

State Street first reported a position in EDSA in Q3 2021 and has held it in 12 quarters since. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

State Street held 37,979 shares of Edesa Biotech worth $309K as of Q2 2026.
State Street left its Edesa Biotech share count unchanged in Q2 2026.
Edesa Biotech made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3707 holding.
State Street first reported a position in Edesa Biotech in Q3 2021 and has held it in 12 quarters since.
33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.